RxDoctor Payments Data

Kevin Adkins

Family Medicine · Mountain Home, ARNPI 1356311617

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Amgen at 35.3% of the total. Reporting peaked in 2019 at $913 and has fallen 97.6% since, to $22 in 2022.

$1,521in general payments, 2019–2025

Across 116 payments — averaging $13.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$537
  • Novo Nordisk$254
  • Astellas Pharma US Inc$159
  • Sanofi-aventis U.S. LLC$149
  • AstraZeneca$124
  • GSK$74
  • plus $224 from 9 others
$1,178in research payments, 2019–2025

Across 4 payments — averaging $294.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$1K

What the payments were for

  • Food & beverage$1,521100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,521 in reported general payments places this provider in the 65th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Other family medicine in Mountain Home

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →